Anatomic Pathology Market Size, Prominent Players and Key Figures Reviewed in Latest Research Report 2021-2026
The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomic pathology market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growing focus on personalized medicine.
Anatomic pathology is a medical...
Anatomic Pathology Market To Reach USD 46.8 Billion By 2025 Growing Focus On Personalized Medicine
What This Report Will Provide?
This study involved four major activities in estimating the current size of the anatomic pathology market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.
Expected...
Anatomic Pathology Market to Witness a Pronounce Growth During 2025
The growth in this market is majorly driven by the high incidence of cancer and other target diseases, availability of reimbursement, and the growing focus on personalized medicine. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to a certain extent during the forecast period.
What the Market Looks...
Anatomic Pathology Market Statistical Forecast, Trade Analysis 2022 – F. Hoffmann-La Roche AG, Danaher Corporation
According to market research analysts, the Anatomic Pathology market is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period. Reports provide insights regarding the lucrative market opportunities within the Anatomic Pathology Market at the country level. Furthermore, the report outlines a detailed cost, segment, trend, region, and commercial development...
Anatomic Pathology Market | Key Players Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Sakura Finetechnical Co Ltd, Quest Diagnostics Incorporated
Growth can be attributed to increasing ageing population; increasing prevalence of chronic diseases and the subsequent growth in the number of anatomic pathology tests. For instance, According to the WHO, the population aged 60 years and over across the globe is expected to double from about 11% in 2000 to 22% in 2050. The number of people over 60 years of age will increase from 605 million to 2 Billion...